Research ArticleArticle
Nicotine-Induced Structural Plasticity in Mesencephalic Dopaminergic Neurons Is Mediated by Dopamine D3 Receptors and Akt-mTORC1 Signaling
Ginetta Collo, Federica Bono, Laura Cavalleri, Laura Plebani, Stefania Mitola, Emilio Merlo Pich, Mark J. Millan, Michele Zoli, Uwe Maskos, PierFranco Spano and Cristina Missale
Molecular Pharmacology June 2013, 83 (6) 1176-1189; DOI: https://doi.org/10.1124/mol.113.084863
Ginetta Collo
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Federica Bono
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Laura Cavalleri
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Laura Plebani
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Stefania Mitola
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Emilio Merlo Pich
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Mark J. Millan
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Michele Zoli
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Uwe Maskos
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
PierFranco Spano
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
Cristina Missale
Department of Molecular and Translational Medicine (G.C., F.B., L.C., L.P., S.M., PF.S., C.M.) and Woman Health Center–Camillo Golgi Foundation (G.C., F.B., L.C., PF.S., C.M.), University of Brescia, Brescia, Italy; Neuroscience Pharmaceutical Division, Hoffman-La Roche, Basel, Switzerland (E.M.P.); Division of Psychopharmacology, Institut de Recherches Servier, Croissy-Sur-Seine, France (M.J.M.); Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy (M.Z.); and Unité de Neurobiologie Intégrative des Systèmes Cholinergiques, Centre National de la Recherche Scientifique, Unité de Recherche Associée 2182, Institut Pasteur, Paris, France (U.M.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Nicotine-Induced Structural Plasticity in DA Neurons
Ginetta Collo, Federica Bono, Laura Cavalleri, Laura Plebani, Stefania Mitola, Emilio Merlo Pich, Mark J. Millan, Michele Zoli, Uwe Maskos, PierFranco Spano and Cristina Missale
Molecular Pharmacology June 1, 2013, 83 (6) 1176-1189; DOI: https://doi.org/10.1124/mol.113.084863
Research ArticleArticle
Nicotine-Induced Structural Plasticity in DA Neurons
Ginetta Collo, Federica Bono, Laura Cavalleri, Laura Plebani, Stefania Mitola, Emilio Merlo Pich, Mark J. Millan, Michele Zoli, Uwe Maskos, PierFranco Spano and Cristina Missale
Molecular Pharmacology June 1, 2013, 83 (6) 1176-1189; DOI: https://doi.org/10.1124/mol.113.084863
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement